<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04560959</url>
  </required_header>
  <id_info>
    <org_study_id>LYS-[2020]-051</org_study_id>
    <nct_id>NCT04560959</nct_id>
  </id_info>
  <brief_title>Atlas of Intracranial Recordings on Cortical Responses After Functional tACS</brief_title>
  <acronym>AIRCRAFT</acronym>
  <official_title>An Atlas of Cerebral Responses to the Stimuli of the tACS Recorded by SEEG</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xuanwu Hospital, Beijing</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Xuanwu Hospital, Beijing</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      By analyzing the SEEG recordings, we explore the range of cortical functional responses to&#xD;
      strings of 77.5Hz stimulations delivered by tACS,&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 20, 2020</start_date>
  <completion_date type="Anticipated">December 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2021</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes of intracranial activities</measure>
    <time_frame>Within 250 ms immediately after the stimulation.</time_frame>
    <description>The change of the power in a band of 0-200 HZ according to the intracranial EEG recording.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Frequency of the epileptic discharges</measure>
    <time_frame>50 minutes during the stimulation and 50 minutes of the interictal baseline before the intervention during the same hour of the day</time_frame>
    <description>To count the numbers of epileptic discharges within the same duration before and when tACS intervention.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Event related potential (ERP)</measure>
    <time_frame>Baseline: 24 hours before the tACS intervention; Observation: Immediately after the end of the tACS intervention.</time_frame>
    <description>ERP related to cognitive tasks before and immediately after the tACS intervention</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Transcranial Alternating Current Stimulation</condition>
  <arm_group>
    <arm_group_label>tACS arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The patient would receive strings of tACS stimulations in 77.5 HZ, each string would last for 1 second, followed by an interval of 5 seconds. A total of 600 strings would be sent out to the patients.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>tACS</intervention_name>
    <description>tACS would be performed to epilepsy patients who have already received implantation of the SEEG electrodes</description>
    <arm_group_label>tACS arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All epileptic patients that would receive the implantation of SEEG electrodes,&#xD;
             regardless of the seizure locations;&#xD;
&#xD;
          -  There was no metal implantation before;&#xD;
&#xD;
          -  Eligible for MRI examination;&#xD;
&#xD;
          -  No other lesional neurological disorders;&#xD;
&#xD;
          -  Could be well informed by the study protocols.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Suffered from any other mental illnesses prior to the enrollment;&#xD;
&#xD;
          -  Those suffering from the serious or unstable organic diseases;&#xD;
&#xD;
          -  Pregnant or lactation women, and those who have a plan of pregnant;&#xD;
&#xD;
          -  Patients with central nervous system tumors, acute brain injury or infection;&#xD;
&#xD;
          -  Skin injured, or allergic to the exposure of the conductive gel;&#xD;
&#xD;
          -  Those with implanted devices;&#xD;
&#xD;
          -  Those who received modified electrical convulsive therapy, or TMS within the recent&#xD;
             one month;&#xD;
&#xD;
          -  The score of item 3 (suicidal item) in HAMD-17 equal or greater than 3;&#xD;
&#xD;
          -  Enrolled in any other on going trials;&#xD;
&#xD;
          -  Other situations evaluated by the researchers as inappropriate to the enrollment&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>G.G. Zhao</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Neurosurgery, Capital Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>P.H. Wei</last_name>
    <phone>+86-010-83198252</phone>
    <email>weipenghu@xwhosp.org</email>
  </overall_contact>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>August 7, 2020</study_first_submitted>
  <study_first_submitted_qc>September 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 23, 2020</study_first_posted>
  <last_update_submitted>September 17, 2020</last_update_submitted>
  <last_update_submitted_qc>September 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

